Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Innocan Pharma Corp (INNO.CN)

Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Innocan Pharma Corp 1015, 926 - 5 Avenue SW Calgary AB T2P 0N7 CAN

https://www.innocanpharma.com P: 403-777-1519

Description:

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.

Key Statistics

Overview:

Market Capitalization, $K 54,518
Shares Outstanding, K 286,938
Annual Sales, $ 13,657 K
Annual Net Income, $ -4,700 K
Last Quarter Sales, $ 8,624 K
Last Quarter Net Income, $ -290 K
60-Month Beta 1.05
% of Institutional Shareholders 0.18%

Growth:

1-Year Return -28.81%
3-Year Return -76.25%
5-Year Return 18.75%

Per-Share Information:

Most Recent Earnings 0.00 on 11/20/24
Next Earnings Date N/A
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Year -57.89%
Dividend Payout Ratio 0.00%

INNO.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -55.06%
Return-on-Assets % -31.63%
Profit Margin % -34.41%
Debt/Equity 0.00
Price/Sales 1.25
Price/Book 7.35
Book Value/Share 0.03
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar